Evidence map›Paper›PMID 33322215›Full record

ArticleCancers2020

Role of Hypoxia and the Adenosine System in Immune Evasion and Prognosis of Patients with Brain Metastases of Melanoma: A Multiplex Whole Slide Immunofluorescence Study.

Arnulf Mayer, Maximilian Haist, Carmen Loquai, Stephan Grabbe, Matthias Rapp, Wilfried Roth, Peter Vaupel, Heinz Schmidberger

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Hyperglycemia is associated with poor survival in patients with brain metastases treated with radiotherapy.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. CD8Frontiers in immunology · 2022
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Arnulf MayerDepartment of Radiation Oncology, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany.ORCID 0000-0002-3101-9180
Maximilian HaistDepartment of Radiation Oncology, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany.
Carmen LoquaiDepartment of Dermatology, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany.
Stephan GrabbeDepartment of Dermatology, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany.ORCID 0000-0002-6863-8719
Matthias RappDepartment of Radiation Oncology, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany.
Wilfried RothInstitute of Pathology, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany.
Peter VaupelDepartment of Radiation Oncology, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany.ORCID 0000-0003-4238-3188
Heinz SchmidbergerDepartment of Radiation Oncology, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany.ORCID 0000-0003-0647-8884
Johannes Gutenberg University Mainz · DE

Funding

Varian Medical Systems Role of adenosine mediated immunosuppression for radiotherapy of melanoma
6 · The paper itself

Abstract

Following the introduction of immune checkpoint inhibitors, a substantial prolongation of the overall survival has been achieved for many patients with multiple brain metastases from melanoma. However, heterogeneity between individual tumor responses is incompletely understood. In order to determine the impact of the individual tumor phenotype on the prognosis of melanoma patients, we examined surgical sections from 33 patients who were treated with radiotherapy (whole-brain radiotherapy, WBRT, stereotactic radiotherapy, STX, or both) and Ipilimumab. We analyzed multiplex staining of the hypoxia marker GLUT-1, the adenosine (ADO)-associated enzymes CD73 and CD39, and CD8, a marker of cytotoxic T lymphocytes (CTL) on a single-cell basis using QuPath. Additionally, the MOSAIC interaction analysis algorithm was used to explore the hypothesis that CTL systematically avoid GLUT-1

Indexed as

adenosinehypoxiaimmune checkpoint inhibitorimmunosuppressionipilimumabmultiplex immunohistochemistryradiotherapyspatial statisticstumor microenvironment

Identifiers

PMID33322215
PMCPMC7763902
OpenAlexW3111072239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.